TB Case Managers

Tuberculosis Testing
Nationwide Shortage of Tuberulin Skin Test Antigens
The Centers for Disease Control and Prevention (CDC) is expecting a 3 to 10 month nationwide shortage of APLISOLĀ®,
a product of Par Pharmaceuticals. APLISOLĀ® is one of two purified-protein derivative (PPD) tuberculin antigens
that are licensed by the United States Food and Drug Administration (FDA) for use in performing tuberculin skin tests.
Follow this link for recommendations on testing and screening for tuberculosis during this period of shortage.
Nationwide Shortage of Tuberculin Skin Test Antigens.
Tuberculosis Medications and Pharmacy Information
North Dakota Tuberculosis Medications Procedure Manual
Active Tuberculosis Medications Request Form
Latent Tuberculosis Medications Request Form
Latent Tuberculosis Medication Start Date Form
INH Fact Sheet
Rifampin Fact Sheet
Rifampin Side Effect Checklist
Class Arrivals and Immigration Documents
North Dakota TB Class Arrivals Instructions
North Dakota Immigrant and Refugee Class Arrival Instructions
Active Tuberculosis Information
Home Respiratory Precautions for Patients with Potentially Infectious TB
Hospital Discharge Planning Checklist
Effective Interviewing for Tuberculosis Contact Investigation
Tuberculosis Reporting
Tuberculosis Infection Report Card--Fillable PDF
Tuberculosis Reimbursement Form
TB Case Management RFR
TB Surveillance RFR